- Record annual revenue of $1.2 billion, up 9 percent
- Record fourth-quarter revenue of $308.5 million
- GAAP net income of $26.1 million, or $0.18 per diluted share
- Non-GAAP net income of $34.3 million, or $0.24 per diluted share
BILLERICA, Mass., Feb. 02, 2017 (GLOBE NEWSWIRE) -- Entegris, Inc. (Nasdaq:ENTG), a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, today reported its financial results for the Company’s fourth quarter and fiscal year ended December 31, 2016.
The Company reported sales of $1.2 billion for the 2016 fiscal year, an increase of 9 percent from the prior year. Net income for fiscal 2016 was $97.1 million, or $0.68 per share, which included amortization of intangible assets of $44.3 million, asset impairment charges of $5.8 million related to certain production equipment and $2.4 million of severance expenses related to an organizational realignment. In the prior year, net income was $80.3 million, or $0.57 per share, which included amortization of intangible assets of $47.3 million and acquisition integration expenses of $12.7 million. Non-GAAP net income for fiscal 2016 was $132.8 million, or $0.94 per diluted share, which increased from $120.6 million, or $0.85 per diluted share, in the prior year.
Fourth-quarter sales were $308.5 million, an increase of 16 percent from the same quarter last year and a 4 percent increase sequentially. Fourth-quarter net income was $26.1 million, or $0.18 per diluted share, which included amortization of intangible assets of $10.9 million. Non-GAAP net income was $34.3 million, or $0.24 per diluted share. In the fourth quarter, the Company generated cash from operations less capital expenditures, or free cash flow, of $37.1 million.
Bertrand Loy, president and chief executive officer, said: "The strong results in the fourth quarter capped a record year in which we grew revenue 9 percent organically, well in excess of our markets. This performance demonstrates that our investments in R&D and innovation over the past few years are paying off, allowing us to expand our served markets and grow our market share. In 2016, we also achieved record non-GAAP earnings per share of $0.94 and generated an adjusted EBITDA of $264 million, an increase of 13 percent from the prior year. This is an all-time high and essentially twice the level we generated prior to the ATMI acquisition in 2014."
"In the fourth quarter, we achieved sales growth above our expectations driven in part by a rebound in our specialty gas products and record demand of our microfiltration, wafer handling, and advanced deposition solutions."
Mr. Loy added: "We believe the industry is in the midst of a multi-year period of wafer growth driven by the ramp of new technologies and expanding end-market demand for semiconductors. New materials are becoming increasingly important to deliver better semiconductor performance and we believe our broad portfolio of solutions puts us in an excellent position to holistically address our customers' needs for materials performance, purity and stability throughout their supply chains and manufacturing processes."
Quarterly Financial Results Summary
(in thousands, except per share data)
| GAAP Results | Q4-2016 | Q4-2015 | Q3-2016 | ||||||
| Net sales | $ | 308,502 | $ | 266,786 | $ | 296,692 | |||
| Operating income | $ | 44,905 | $ | 20,116 | $ | 34,672 | |||
| Operating margin | 14.6 | % | 7.5 | % | 11.7 | % | |||
| Net income | $ | 26,098 | $ | 17,573 | $ | 21,947 | |||
| Diluted earnings per share (EPS) | $ | 0.18 | $ | 0.12 | $ | 0.15 | |||
| Non-GAAP Results | |||||||||
| Non-GAAP adjusted operating income | $ | 55,843 | $ | 37,141 | $ | 53,877 | |||
| Adjusted operating margin | 18.1 | % | 13.9 | % | 18.2 | % | |||
| Non-GAAP net income | $ | 34,294 | $ | 28,822 | $ | 34,647 | |||
| Non-GAAP EPS | $ | 0.24 | $ | 0.20 | $ | 0.24 | |||
First-Quarter Outlook
For the first quarter ending April 1, 2017, the Company expects sales of $295 million to $310 million, net income of $25 million to $31 million, and net income per diluted share between $0.18 and $0.22. On a non-GAAP basis, EPS is expected to range from $0.23 to $0.27 per diluted share, which reflects net income on a non-GAAP basis in the range of $32 million to $38 million, which is adjusted for expected amortization expense of approximately $11 million or $0.05 per share.
Segment Results
The Company has changed its financial segment reporting, reflecting an organizational realignment intended to better leverage its unique portfolio of capabilities to create value for its customers by developing mission-critical solutions to maximize manufacturing yields and enable higher performance of devices. The Company's business is reported in the following segments:
Microcontamination Control (MC): MC solutions purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides high-performance and high-purity process chemistries, gases, and materials and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Advanced Materials Handling (AMH): AMH develops solutions to monitor, protect, transport, and deliver critical liquid chemistries and substrates for a broad set of applications in the semiconductor industry and other high-technology industries.
Fourth-Quarter Results Conference Call Details
Entegris will hold a conference call to discuss its results for the fourth quarter and fiscal year on Thursday, February 2, 2017, at 10:00 a.m. Eastern Time. Participants should dial 1-888-600-4869 or 1-913-312-0936, referencing confirmation code 4935351. Participants are asked to dial in 5 to 10 minutes prior to the start of the call. To access a telephonic replay of the call, please Click Here. The replay will be available starting at 1:00 p.m. ET on Thursday, February 2 until Saturday, March 18. A live and on-demand webcast of the call can also be accessed from the investor relations section of Entegris’ website at www.entegris.com.
Management’s slide presentation concerning the results for the fourth quarter and fiscal year, which may be referred to during the call, will be posted on the investor relations section of www.entegris.com Thursday morning before the call.
ABOUT ENTEGRIS
Entegris is a leader in specialty chemicals and advanced materials solutions for the microelectronics industry and other high-tech industries. Entegris is ISO 9001 certified and has manufacturing, customer service and/or research facilities in the United States, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea and Taiwan. Additional information can be found at www.entegris.com.
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in the United States (GAAP). Adjusted EBITDA, Adjusted Gross Profit, Adjusted Segment Profit, and Adjusted Operating Income together with related measures thereof, and non-GAAP EPS, are considered “Non-GAAP financial measures” under the rules and regulations of the Securities and Exchange Commission. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. These financial measures are provided as a supplement to financial measures provided in accordance with GAAP. We provide non-GAAP financial measures in order to further assess and measure operating performance. Management believes the non-GAAP measures provide meaningful supplemental information regarding our baseline performance before certain gains, losses or other charges that may not be indicative of our business or future outlook. We believe these non-GAAP measures will aid investors’ overall understanding of our results by providing a higher degree of transparency for certain expenses and providing a level of disclosure that will help investors understand how we plan and measure our business. The reconciliations of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA, GAAP Gross Profit to Adjusted Gross Profit, GAAP Segment Profit to Adjusted Operating Income, and GAAP to Non-GAAP Earnings per Share are included elsewhere in this release.
Forward-Looking Statements
Certain information contained in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current management expectations only as of the date of this press release, and involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. Statements that include such words as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “may,” “will,” “should” or the negative thereof and similar expressions as they relate to Entegris or our management are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These risks include, but are not limited to, fluctuations in the market price of Entegris’ stock, Entegris’ future operating results, other acquisition and investment opportunities available to Entegris, general business and market conditions and other factors. Additional information concerning these and other risk factors may be found in previous financial press releases issued by Entegris and Entegris’ periodic public filings with the Securities and Exchange Commission, including discussions appearing under the headings “Risks Relating to our Business and Industry,” “Risks Relating to Our Indebtedness,” “Manufacturing Risks,” “International Risks,” and “Risks Related to Owning Our Common Stock” in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed with the U.S Securities and Exchange Commission on February 29, 2016, as well as other matters and important factors disclosed previously and from time to time in the filings of Entegris with the U.S. Securities and Exchange Commission. Except as required under the federal securities laws and the rules and regulations of the Securities and Exchange Commission, we undertake no obligation to update publicly any forward-looking statements contained herein.
| Entegris, Inc. and Subsidiaries | |||||||||
| Condensed Consolidated Statements of Operations | |||||||||
| (In thousands, except per share data) | |||||||||
| (Unaudited) | |||||||||
| Three months ended | |||||||||
| December 31, 2016 | December 31, 2015 | October 1, 2016 | |||||||
| Net sales | $ | 308,502 | $ | 266,786 | $ | 296,692 | |||
| Cost of sales | 176,702 | 157,488 | 173,712 | ||||||
| Gross profit | 131,800 | 109,298 | 122,980 | ||||||
| Selling, general and administrative expenses | 48,734 | 51,024 | 51,614 | ||||||
| Engineering, research and development expenses | 27,223 | 26,717 | 25,720 | ||||||
| Amortization of intangible assets | 10,938 | 11,441 | 10,974 | ||||||
| Operating income | 44,905 | 20,116 | 34,672 | ||||||
| Interest expense, net | 8,983 | 9,694 | 9,345 | ||||||
| Other expense (income), net | 1,303 | (3,889 | ) | (565 | ) | ||||
| Income before income tax expense (benefit) and equity in net loss of affiliates | 34,619 | 14,311 | 25,892 | ||||||
| Income tax expense (benefit) | 8,521 | (4,731 | ) | 3,945 | |||||
| Equity in net loss of affiliates | — | 1,469 | — | ||||||
| Net income | $ | 26,098 | $ | 17,573 | $ | 21,947 | |||
| Basic net income per common share: | $ | 0.18 | $ | 0.13 | $ | 0.16 | |||
| Diluted net income per common share: | $ | 0.18 | $ | 0.12 | $ | 0.15 | |||
| Weighted average shares outstanding: | |||||||||
| Basic | 141,315 | 140,567 | 141,324 | ||||||
| Diluted | 142,631 | 141,433 | 142,473 | ||||||
| Entegris, Inc. and Subsidiaries | ||||||
| Condensed Consolidated Statements of Operations | ||||||
| (In thousands, except per share data) | ||||||
| (Unaudited) | ||||||
| Twelve months ended | ||||||
| December 31, 2016 | December 31, 2015 | |||||
| Net sales | $ | 1,175,270 | $ | 1,081,121 | ||
| Cost of sales | 666,579 | 610,890 | ||||
| Gross profit | 508,691 | 470,231 | ||||
| Selling, general and administrative expenses | 201,901 | 198,914 | ||||
| Engineering, research and development expenses | 106,991 | 105,900 | ||||
| Amortization of intangible assets | 44,263 | 47,349 | ||||
| Operating income | 155,536 | 118,068 | ||||
| Interest expense, net | 36,528 | 38,238 | ||||
| Other income, net | (991 | ) | (12,355 | ) | ||
| Income before income tax expense and equity in net loss of affiliates | 119,999 | 92,185 | ||||
| Income tax expense | 22,852 | 10,202 | ||||
| Equity in net loss of affiliates | — | 1,687 | ||||
| Net income | $ | 97,147 | $ | 80,296 | ||
| Basic net income per common share: | $ | 0.69 | $ | 0.57 | ||
| Diluted net income per common share: | $ | 0.68 | $ | 0.57 | ||
| Weighted average shares outstanding: | ||||||
| Basic | 141,093 | 140,353 | ||||
| Diluted | 142,050 | 141,121 | ||||
| Entegris, Inc. and Subsidiaries | |||||||
| Condensed Consolidated Balance Sheets | |||||||
| (In thousands) | |||||||
| (Unaudited) | |||||||
| December 31, 2016 | December 31, 2015 | ||||||
| ASSETS | |||||||
| Cash and cash equivalents | $ | 406,389 | $ | 349,825 | |||
| Short-term investments | — | 2,181 | |||||
| Accounts receivable, net | 165,675 | 141,409 | |||||
| Inventories | 183,529 | 173,176 | |||||
| Deferred tax assets, deferred tax charges and refundable income taxes | 20,140 | 18,943 | |||||
| Other current assets | 24,398 | 23,253 | |||||
| Total current assets | 800,131 | 708,787 | |||||
| Property, plant and equipment, net | 321,562 | 321,301 | |||||
| Goodwill | 345,269 | 342,111 | |||||
| Intangible assets | 217,548 | 258,942 | |||||
| Deferred tax assets - non-current | 8,022 | 7,771 | |||||
| Other assets | 7,000 | 7,785 | |||||
| Total assets | $ | 1,699,532 | $ | 1,646,697 | |||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||
| Long-term debt, current maturities | $ | 100,000 | $ | 50,000 | |||
| Accounts payable | 61,617 | 36,916 | |||||
| Accrued liabilities | 83,530 | 75,859 | |||||
| Income tax payable and deferred tax liabilities | 16,424 | 12,775 | |||||
| Total current liabilities | 261,571 | 175,550 | |||||
| Long-term debt, excluding current maturities | 484,677 | 606,044 | |||||
| Other liabilities | 54,066 | 62,220 | |||||
| Shareholders’ equity | 899,218 | 802,883 | |||||
| Total liabilities and shareholders’ equity | $ | 1,699,532 | $ | 1,646,697 | |||
| Entegris, Inc. and Subsidiaries | ||||||||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||||||
| (In thousands) | ||||||||||||
| (Unaudited) | ||||||||||||
| Three months ended | Twelve months ended | |||||||||||
| December 31, 2016 | December 31, 2015 | December 31, 2016 | December 31, 2015 | |||||||||
| Operating activities: | ||||||||||||
| Net income | $ | 26,098 | $ | 17,573 | $ | 97,147 | $ | 80,296 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation | 14,303 | 14,225 | 55,623 | 54,305 | ||||||||
| Amortization | 10,938 | 11,441 | 44,263 | 47,349 | ||||||||
| Stock-based compensation expense | 3,373 | 2,913 | 13,436 | 11,033 | ||||||||
| Provision for deferred income taxes | (15,770 | ) | (15,907 | ) | (16,104 | ) | (13,313 | ) | ||||
| Other | 3,326 | (1,999 | ) | 22,993 | (14,101 | ) | ||||||
| Changes in operating assets and liabilities: | ||||||||||||
| Trade accounts and notes receivable | (3,046 | ) | 43,232 | (25,298 | ) | 5,212 | ||||||
| Inventories | (2,575 | ) | 12,880 | (19,871 | ) | (26,670 | ) | |||||
| Accounts payable and accrued liabilities | 4,777 | (41,262 | ) | 31,294 | (28,686 | ) | ||||||
| Income taxes payable and refundable income taxes | 14,592 | 8,602 | 3,228 | 4,955 | ||||||||
| Other | 1,063 | 520 | 844 | 538 | ||||||||
| Net cash provided by operating activities | 57,079 | 52,218 | 207,555 | 120,918 | ||||||||
| Investing activities: | ||||||||||||
| Acquisition of property and equipment | (19,992 | ) | (16,281 | ) | (65,260 | ) | (71,977 | ) | ||||
| Proceeds from sale and maturities of investments | 94 | 5,581 | 1,726 | 7,692 | ||||||||
| Other | — | 300 | (3,152 | ) | 647 | |||||||
| Net cash used in investing activities | (19,898 | ) | (10,400 | ) | (66,686 | ) | (63,638 | ) | ||||
| Financing activities: | ||||||||||||
| Payments on long-term debt | (25,000 | ) | — | (75,000 | ) | (100,000 | ) | |||||
| Issuance of common stock | 1,952 | 1,656 | 4,844 | 4,264 | ||||||||
| Taxes paid related to net share settlement of equity awards | (702 | ) | (50 | ) | (4,018 | ) | (2,508 | ) | ||||
| Other | (4,493 | ) | 4,792 | (7,573 | ) | 5,457 | ||||||
| Net cash (used in) provided by financing activities | (28,243 | ) | 6,398 | (81,747 | ) | (92,787 | ) | |||||
| Effect of exchange rate changes on cash | (14,326 | ) | 548 | (2,558 | ) | (4,367 | ) | |||||
| (Decrease) increase in cash and cash equivalents | (5,388 | ) | 48,764 | 56,564 | (39,874 | ) | ||||||
| Cash and cash equivalents at beginning of period | 411,777 | 301,061 | 349,825 | 389,699 | ||||||||
| Cash and cash equivalents at end of period | $ | 406,389 | $ | 349,825 | $ | 406,389 | $ | 349,825 | ||||
| Entegris, Inc. and Subsidiaries | |||||||||||||||
| Segment Information | |||||||||||||||
| (In thousands) | |||||||||||||||
| (Unaudited) | |||||||||||||||
| Three months ended | Twelve months ended | ||||||||||||||
| Net sales | December 31, 2016 | December 31, 2015 | October 1, 2016 | December 31, 2016 | December 31, 2015 | ||||||||||
| Specialty Chemicals and Engineered Materials | $ | 110,945 | $ | 103,127 | $ | 104,494 | $ | 428,328 | $ | 418,878 | |||||
| Advanced Materials Handling | 98,840 | 81,567 | 97,460 | 384,284 | 346,426 | ||||||||||
| Microcontamination Control | 98,717 | 82,092 | 94,738 | 362,658 | 315,817 | ||||||||||
| Total net sales | $ | 308,502 | $ | 266,786 | $ | 296,692 | $ | 1,175,270 | $ | 1,081,121 | |||||
| Three months ended | Twelve months ended | ||||||||||||||
| Segment profit | December 31, 2016 | December 31, 2015 | October 1, 2016 | December 31, 2016 | December 31, 2015 | ||||||||||
| Specialty Chemicals and Engineered Materials | $ | 25,919 | $ | 24,218 | $ | 18,811 | $ | 96,060 | $ | 100,370 | |||||
| Advanced Materials Handling | 16,644 | 10,094 | 15,378 | 73,452 | 66,419 | ||||||||||
| Microcontamination Control | 31,719 | 20,671 | 31,617 | 110,042 | 83,076 | ||||||||||
| Total segment profit | 74,282 | 54,983 | 65,806 | 279,554 | 249,865 | ||||||||||
| Amortization of intangibles | 10,938 | 11,441 | 10,974 | 44,263 | 47,349 | ||||||||||
| Unallocated expenses | 18,439 | 23,426 | 20,160 | 79,755 | 84,448 | ||||||||||
| Total operating income | $ | 44,905 | $ | 20,116 | $ | 34,672 | $ | 155,536 | $ | 118,068 | |||||
| Entegris, Inc. and Subsidiaries | ||||||||||||||||||||
| Reconciliation of GAAP Net Income to Adjusted Operating Income and Adjusted EBITDA | ||||||||||||||||||||
| (In thousands) | ||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||
| Three months ended | Twelve months ended | |||||||||||||||||||
| December 31, 2016 | December 31, 2015 | October 1, 2016 | December 31, 2016 | December 31, 2015 | ||||||||||||||||
| Net sales | $ | 308,502 | $ | 266,786 | $ | 296,692 | $ | 1,175,270 | $ | 1,081,121 | ||||||||||
| Net income | $ | 26,098 | $ | 17,573 | $ | 21,947 | $ | 97,147 | $ | 80,296 | ||||||||||
| Adjustments to net income: | ||||||||||||||||||||
| Equity in net loss of affiliates | — | 1,469 | — | — | 1,687 | |||||||||||||||
| Income tax expense (benefit) | 8,521 | (4,731 | ) | 3,945 | 22,852 | 10,202 | ||||||||||||||
| Interest expense, net | 8,983 | 9,694 | 9,345 | 36,528 | 38,238 | |||||||||||||||
| Other expense (income), net | 1,303 | (3,889 | ) | (565 | ) | (991 | ) | (12,355 | ) | |||||||||||
| GAAP - Operating income | 44,905 | 20,116 | 34,672 | 155,536 | 118,068 | |||||||||||||||
| Severance related to organizational realignment | — | — | 2,405 | 2,405 | — | |||||||||||||||
| Impairment of equipment | — | — | 5,826 | 5,826 | — | |||||||||||||||
| Integration costs | 5,584 | — | — | 12,667 | ||||||||||||||||
| Amortization of intangible assets | 10,938 | 11,441 | 10,974 | 44,263 | 47,349 | |||||||||||||||
| Adjusted operating income | 55,843 | 37,141 | 53,877 | 208,030 | 178,084 | |||||||||||||||
| Depreciation | 14,303 | 14,225 | 13,795 | 55,623 | 54,305 | |||||||||||||||
| Adjusted EBITDA | $ | 70,146 | $ | 51,366 | $ | 67,672 | $ | 263,653 | $ | 232,389 | ||||||||||
| Adjusted operating margin | 18.1 | % | 13.9 | % | 18.2 | % | 17.7 | % | 16.5 | % | ||||||||||
| Adjusted EBITDA - as a % of net sales | 22.7 | % | 19.3 | % | 22.8 | % | 22.4 | % | 21.5 | % | ||||||||||
| Entegris, Inc. and Subsidiaries | ||||||||||||||||
| Reconciliation of GAAP Gross Profit to Adjusted Gross Profit | ||||||||||||||||
| (In thousands) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| Three months ended | Twelve months ended | |||||||||||||||
| December 31, 2016 | December 31, 2015 | October 1, 2016 | December 31, 2016 | December 31, 2015 | ||||||||||||
| Net sales | $ | 308,502 | $ | 266,786 | $ | 296,692 | $ | 1,175,270 | $ | 1,081,121 | ||||||
| Gross profit-GAAP | $ | 131,800 | $ | 109,298 | $ | 122,980 | $ | 508,691 | $ | 470,231 | ||||||
| Adjustments to gross profit: | ||||||||||||||||
| Severance related to organizational realignment | — | — | 431 | 431 | — | |||||||||||
| Impairment of equipment | — | — | 5,826 | 5,826 | — | |||||||||||
| Adjusted gross profit | $ | 131,800 | $ | 109,298 | $ | 129,237 | $ | 514,948 | $ | 470,231 | ||||||
| Gross margin - as a % of net sales | 42.7 | % | 41.0 | % | 41.5 | % | 43.3 | % | 43.5 | % | ||||||
| Adjusted gross margin - as a % of net sales | 42.7 | % | 41.0 | % | 43.6 | % | 43.8 | % | 43.5 | % | ||||||
| Entegris, Inc. and Subsidiaries | |||||||||||||||
| Reconciliation of GAAP Segment Profit to Adjusted Operating Income | |||||||||||||||
| (In thousands) | |||||||||||||||
| (Unaudited) | |||||||||||||||
| Three months ended | Twelve months ended | ||||||||||||||
| Segment profit-GAAP | December 31, 2016 | December 31, 2015 | October 1, 2016 | December 31, 2016 | December 31, 2015 | ||||||||||
| Specialty Chemicals and Engineered Materials | $ | 25,919 | $ | 24,218 | $ | 18,811 | $ | 96,060 | $ | 100,370 | |||||
| Advanced Materials Handling | 16,644 | 10,094 | 15,378 | 73,452 | 66,419 | ||||||||||
| Microcontamination Control | 31,719 | 20,671 | 31,617 | 110,042 | 83,076 | ||||||||||
| Total segment profit | 74,282 | 54,983 | 65,806 | 279,554 | 249,865 | ||||||||||
| Amortization of intangible assets | 10,938 | 11,441 | 10,974 | 44,263 | 47,349 | ||||||||||
| Unallocated expenses | 18,439 | 23,426 | 20,160 | 79,755 | 84,448 | ||||||||||
| Total operating income | $ | 44,905 | $ | 20,116 | $ | 34,672 | $ | 155,536 | $ | 118,068 | |||||
| Three months ended | Twelve months ended | ||||||||||||||
| Adjusted segment profit | December 31, 2016 | December 31, 2015 | October 1, 2016 | December 31, 2016 | December 31, 2015 | ||||||||||
| Specialty Chemicals and Engineered Materials 1 | $ | 25,919 | $ | 24,218 | $ | 19,510 | $ | 96,759 | $ | 100,370 | |||||
| Advanced Materials Handling 2 | 16,644 | 10,094 | 22,173 | 80,247 | 66,419 | ||||||||||
| Microcontamination Control 3 | 31,719 | 20,671 | 32,354 | 110,779 | 83,076 | ||||||||||
| Total adjusted segment profit | 74,282 | 54,983 | 74,037 | 287,785 | 249,865 | ||||||||||
| Amortization of intangible assets4 | — | — | — | — | — | ||||||||||
| Unallocated expenses5 | 18,439 | 17,842 | 20,160 | 79,755 | 71,781 | ||||||||||
| Total adjusted operating income | $ | 55,843 | $ | 37,141 | $ | 53,877 | $ | 208,030 | $ | 178,084 | |||||
1 Adjusted segment profit for Specialty Chemicals and Engineered Materials for the three months ended October 1, 2016 and twelve months ended December 31, 2016 excludes charges for severance related to organizational realignment of $699.
2 Adjusted segment profit for Advanced Material Handling for the three months ended October 1, 2016 and twelve months ended December 31, 2016 excludes charges for impairment of equipment and severance related to organizational realignment of $5,826 and $969, respectively.
3 Adjusted segment profit for Microcontamination Control for the three months ended October 1, 2016 and twelve months ended December 31, 2016 excludes charges for severance related to organizational realignment of $737.
4 Adjusted amortization of intangible assets excludes amortization expense of $10,938, $11,441, and $10,974 for the three months ended December 31, 2016 and 2015, and October 1, 2016, respectively and $44,263 and $47,349 for the twelve months ended December 31, 2016 and 2015, respectively.
5 Adjusted unallocated expenses exclude integration costs of $5,584 for the three months ended December 31, 2015 and $12,667 for the twelve months ended December 31, 2015.
| Entegris, Inc. and Subsidiaries | ||||||||||||||||
| Reconciliation of GAAP Net Income to Non-GAAP Earnings per Share | ||||||||||||||||
| (In thousands, except per share data) | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| Three months ended | Twelve months ended | |||||||||||||||
| December 31, 2016 | December 31, 2015 | October 1, 2016 | December 31, 2016 | December 31, 2015 | ||||||||||||
| GAAP net income | $ | 26,098 | $ | 17,573 | $ | 21,947 | $ | 97,147 | $ | 80,296 | ||||||
| Adjustments to net income: | ||||||||||||||||
| Severance related to organizational realignment | — | — | 2,405 | 2,405 | — | |||||||||||
| Impairment of equipment | — | — | 5,826 | 5,826 | — | |||||||||||
| Integration costs | — | 5,584 | — | — | 12,667 | |||||||||||
| Net gain on sale of investments | — | (2,016 | ) | — | (156 | ) | (1,449 | ) | ||||||||
| Amortization of intangible assets | 10,938 | 11,441 | 10,974 | 44,263 | 47,349 | |||||||||||
| Tax effect of adjustments to net income and discrete items | (2,742 | ) | (3,760 | ) | (6,505 | ) | (16,637 | ) | (18,248 | ) | ||||||
| Non-GAAP net income | $ | 34,294 | $ | 28,822 | $ | 34,647 | $ | 132,848 | $ | 120,615 | ||||||
| Diluted earnings per common share | $ | 0.18 | $ | 0.12 | $ | 0.15 | $ | 0.68 | $ | 0.57 | ||||||
| Effect of adjustments to net income | $ | 0.06 | $ | 0.08 | $ | 0.09 | $ | 0.25 | $ | 0.29 | ||||||
| Diluted non-GAAP earnings per common share | $ | 0.24 | $ | 0.20 | $ | 0.24 | $ | 0.94 | $ | 0.85 | ||||||